Related references
Note: Only part of the references are listed.Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study
Richard B. Lipton et al.
HEADACHE (2019)
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine The ACHIEVE II Randomized Clinical Trial
Richard B. Lipton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Targeting calcitonin gene-related peptide: a new era in migraine therapy
Andrew Charles et al.
LANCET (2019)
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Kathleen B. Digre
HEADACHE (2019)
Ubrogepant for the Treatment of Migraine
David W. Dodick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Recognizing the role of CGRP and CGRP receptors in migraine and its treatment
Lars Edvinsson et al.
CEPHALALGIA (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study
Richard B. Lipton et al.
HEADACHE (2017)
Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine
Roger K. Cady et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
Michael J. Marmura et al.
HEADACHE (2015)
Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine
D. D'Amico et al.
NEUROLOGICAL SCIENCES (2015)
A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
Roger K. Cady et al.
HEADACHE (2015)
Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination
Stephen H. Landy et al.
HEADACHE (2014)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
Richard B. Lipton et al.
HEADACHE (2013)
Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
Daniel Serrano et al.
VALUE IN HEALTH (2013)
A systematic review of the psychosocial difficulties relevant to patients with migraine
Alberto Raggi et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
A. M. Blumenfeld et al.
CEPHALALGIA (2011)
Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review
Michel Lanteri-Minet et al.
CEPHALALGIA (2011)
Health-Related Quality of Life, Disability and Severity of Disease in Patients With Migraine Attending to a Specialty Headache Center
Matilde Leonardi et al.
HEADACHE (2010)
Direct cost burden among insured US employees with migraine
Kevin Hawkins et al.
HEADACHE (2008)
The cycle of migraine: Patients' quality of life during and between migraine attacks
Frederick G. Freitag
CLINICAL THERAPEUTICS (2007)
Satisfaction with current migraine therapy: Experience from 3 centers in US and Sweden
Marcelo Bigal et al.
HEADACHE (2007)
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy
M. J. A. Lainez et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Disability and quality of life in different primary headaches: results from Italian studies
G Bussone et al.
NEUROLOGICAL SCIENCES (2004)
Global trends in migraine care - Results from the MAZE survey
JL Brandes
CNS DRUGS (2002)
Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan
SS Colman et al.
CLINICAL THERAPEUTICS (2001)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
Share Paper
